Taking into consideration the function of ASPP2 on the suppression of HBV replication by reducing hepatocyte autophagy, ASPP2 is expected to be an ideal treatment strategy for HBV infection‐related liver diseases. The gene discussed is TP53BP2; the disease is liver disorder.